We discovered a VHH-Fc fusion protein with high affinity to ANGPTL3, strong stability and also alleviated the progression of NAFLD, which might offer a promising therapy for NAFLD. This evidence concerns the gene ANGPTL3 and metabolic dysfunction-associated steatotic liver disease.